NZ513869A - Use of moxonidine for postmyocardial infarction treatment - Google Patents

Use of moxonidine for postmyocardial infarction treatment

Info

Publication number
NZ513869A
NZ513869A NZ513869A NZ51386900A NZ513869A NZ 513869 A NZ513869 A NZ 513869A NZ 513869 A NZ513869 A NZ 513869A NZ 51386900 A NZ51386900 A NZ 51386900A NZ 513869 A NZ513869 A NZ 513869A
Authority
NZ
New Zealand
Prior art keywords
myocardial infarction
moxonidine
physiologically compatible
myocardial
management
Prior art date
Application number
NZ513869A
Other languages
English (en)
Inventor
Regina Gertruida Schoemaker
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of NZ513869A publication Critical patent/NZ513869A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heat Treatment Of Articles (AREA)
  • Details Of Spanners, Wrenches, And Screw Drivers And Accessories (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Fire-Extinguishing Compositions (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Farming Of Fish And Shellfish (AREA)
NZ513869A 1999-02-01 2000-01-28 Use of moxonidine for postmyocardial infarction treatment NZ513869A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19903780 1999-02-01

Publications (1)

Publication Number Publication Date
NZ513869A true NZ513869A (en) 2001-09-28

Family

ID=7895940

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ513869A NZ513869A (en) 1999-02-01 2000-01-28 Use of moxonidine for postmyocardial infarction treatment

Country Status (26)

Country Link
US (1) US7041303B2 (xx)
EP (1) EP1150680B1 (xx)
JP (1) JP4686027B2 (xx)
KR (1) KR20010092793A (xx)
CN (1) CN1166363C (xx)
AT (1) ATE286731T1 (xx)
AU (1) AU774855B2 (xx)
BR (1) BR0007894A (xx)
CA (1) CA2361600C (xx)
CZ (1) CZ20012615A3 (xx)
DE (2) DE50009220D1 (xx)
DK (1) DK1150680T3 (xx)
ES (1) ES2235829T3 (xx)
HK (1) HK1042650B (xx)
HU (1) HUP0105210A3 (xx)
IL (1) IL144621A (xx)
NO (1) NO321061B1 (xx)
NZ (1) NZ513869A (xx)
PL (1) PL195124B1 (xx)
PT (1) PT1150680E (xx)
RU (1) RU2261097C2 (xx)
SK (1) SK10082001A3 (xx)
TR (1) TR200102221T2 (xx)
UA (1) UA67822C2 (xx)
WO (1) WO2000045820A1 (xx)
ZA (1) ZA200105827B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102850331B (zh) * 2012-09-17 2015-05-20 符爱清 一种化合物的制备方法
CN103483268B (zh) * 2013-09-17 2015-10-14 常州大学 一种4,6-二氯-2-甲基-5-硝基嘧啶的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3739779A1 (de) * 1987-11-24 1989-06-08 Beiersdorf Ag Pharmazeutische praeparate
DE4423177A1 (de) * 1994-07-01 1996-01-04 Kali Chemie Pharma Gmbh Antihyperglykämisch wirksame Arzneimittel
KR20000016406A (ko) * 1996-06-06 2000-03-25 피터 지. 스트링거 울혈성 심장 마비 치료용 제제 및 방법_

Also Published As

Publication number Publication date
BR0007894A (pt) 2001-10-30
SK10082001A3 (sk) 2002-04-04
NO20013753L (no) 2001-09-28
IL144621A (en) 2004-12-15
NO321061B1 (no) 2006-03-06
US20020045633A1 (en) 2002-04-18
PL195124B1 (pl) 2007-08-31
HK1042650B (zh) 2005-05-06
HUP0105210A3 (en) 2003-01-28
CN1166363C (zh) 2004-09-15
PL350559A1 (en) 2002-12-16
HK1042650A1 (en) 2002-08-23
WO2000045820A1 (de) 2000-08-10
AU2440400A (en) 2000-08-25
CA2361600A1 (en) 2000-08-10
EP1150680B1 (de) 2005-01-12
TR200102221T2 (tr) 2002-01-21
US7041303B2 (en) 2006-05-09
ATE286731T1 (de) 2005-01-15
ZA200105827B (en) 2002-07-16
EP1150680A1 (de) 2001-11-07
HUP0105210A2 (hu) 2002-05-29
RU2261097C2 (ru) 2005-09-27
PT1150680E (pt) 2005-03-31
CA2361600C (en) 2008-08-26
IL144621A0 (en) 2002-05-23
ES2235829T3 (es) 2005-07-16
DE50009220D1 (de) 2005-02-17
CN1338938A (zh) 2002-03-06
DK1150680T3 (da) 2005-03-07
JP4686027B2 (ja) 2011-05-18
AU774855B2 (en) 2004-07-08
DE10003771A1 (de) 2000-08-03
CZ20012615A3 (cs) 2002-01-16
UA67822C2 (uk) 2004-07-15
KR20010092793A (ko) 2001-10-26
NO20013753D0 (no) 2001-07-31
JP2002536334A (ja) 2002-10-29

Similar Documents

Publication Publication Date Title
DK9200258U4 (da) Farmaceutisk præparat indeholdende enalapril til brug mod hypertension
BR9811825A (pt) Uso de lactobacillus para redução do nìvel de fibrinogênio no sangue
BR0212252A (pt) Métodos para reduzir a hipertensão e a insuficiência cardìaca em um mamìfero
WO2001012122A3 (en) Method and system for treating cardiac arrest using hypothermia
CY1109191T1 (el) Μια νεα χρηση της δεφεριπρονης
DK0901790T3 (da) Anvendelse af moxonidin til behandling af neuropatisk smerte
CA2468664A1 (en) Ketorolac tromethamine compositions for treating or preventing ocular pain
NZ513869A (en) Use of moxonidine for postmyocardial infarction treatment
ATE8739T1 (de) Pharmazeutische zubereitungen.
RU96102110A (ru) Способ профилактики и лечения изъязвлений роговицы
NO971453D0 (no) Anvendelse av bradykinin-antagonister for fremstilling av legemidler for behandling av kroniske fibrogenetiske og akutte leversykdommer
NO960347L (no) Anvendelse av benzydamid ved behandling av patologiske tilstander forårsaket av TNF
CA2238920A1 (en) Nephroprotective pharmaceutical composition and use thereof
RU2000117903A (ru) Способ лечения хронического гастрита и язвенной болезни двенадцатиперстной кишки
FI20010233A0 (fi) Menetelmä sydämen vajaatoiminnan hoitoon
CA2069202A1 (en) The use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine in vascular surgery
BR0303384A (pt) Citalopram e seus usos no tratamento de pressão sanguìnea elevada
WO2001039760A3 (en) Method of treating batten disease
BR9913242A (pt) Uso de r(+)-alfa-(2,3-dimetoxifenil)-1-[2-(4-fluorofenil)etil]-4-p iperidinametanol para o tratamento de desordens de sono
MD1469G2 (ro) Metodă de tratament al şocului combustional
RU97110400A (ru) Способ профилактики и лечения больных, страдающих эстрогенно- и андрогенозависимыми опухолями
RU2002109392A (ru) Способ лечения больных псориазом
RU99113212A (ru) Способ лечения поликистозных и кистозных образований
TH43264A (th) องค์ประกอบสำหรับการบำบัดรักษาแผลเรื้อรัง
UA11290U (uk) Спосіб профілактики антрациклінового ушкодження серця

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)